However, topical administration of BPC 157 led to a significant increase in tensile breaking force
No independent research group has conducted a properly powered, double-blind, placebo-controlled trial of topical GHK-Cu for skin aging
BPC-157 and TB-500 operate through fundamentally different molecular mechanisms: BPC-157 modulates the nitric oxide system and upregulates growth factors including EGF, VEGF, and FGF-2 to promote cytoprotection and angiogenesis, while TB-500 sequesters G-actin monomers to regulate actin polymerization, cytoskeletal dynamics, and cell migration
It targets the disc extracellular matrix directly and may help maintain structural integrity before significant herniation occurs
50 mg / 5 mL = 10 mg/mL 2,000 mcg / 10,000 mcg per mL = 0.2 mL = 20 U-100 units 1,000 mcg / 10,000 mcg per mL = 0.1 mL = 10 U-100 units GHK-Cu 100 mg vial with 5 mL example A larger 100 mg vial mixed with 5 mL gives 20 mg/mL, or 20,000 mcg/mL double the strength of the 50 mg example
ISBN 978-0-470-57095-1